Fibrinogen CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. Fibrinogen Gen Silencer sind erhältlich als Fibrinogen CRISPR/Cas9 Knockout Plasmide und Fibrinogen Double Nickase Plasmide. Fibrinogen CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
Fibrinogen CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Fibrinogen α CRISPR/Cas9 KO Plasmid (h) | sc-400793 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen α CRISPR/Cas9 KO Plasmid (h2) | sc-400793-KO-2 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen α HDR Plasmid (h2) | sc-400793-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (h) | sc-400793-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (h2) | sc-400793-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α CRISPR/Cas9 KO Plasmid (m) | sc-420321 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen α HDR Plasmid (m) | sc-420321-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (m) | sc-420321-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (m2) | sc-420321-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β CRISPR/Cas9 KO Plasmid (h) | sc-401819 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen β HDR Plasmid (h) | sc-401819-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (h) | sc-401819-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (h2) | sc-401819-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β CRISPR/Cas9 KO Plasmid (m) | sc-430993 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen β HDR Plasmid (m) | sc-430993-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (m) | sc-430993-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (m2) | sc-430993-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ CRISPR/Cas9 KO Plasmid (h) | sc-416704 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen γ HDR Plasmid (h) | sc-416704-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (h) | sc-416704-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (h2) | sc-416704-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ CRISPR/Cas9 KO Plasmid (m) | sc-430271 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen γ HDR Plasmid (m) | sc-430271-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (m) | sc-430271-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (m2) | sc-430271-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Fibrinogen CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Fibrinogen α CRISPR Activation Plasmid (h) | sc-400793-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (h2) | sc-400793-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (h) | sc-400793-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (h2) | sc-400793-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (m) | sc-420321-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (m2) | sc-420321-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (m) | sc-420321-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (m2) | sc-420321-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (h) | sc-401819-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (h2) | sc-401819-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (h) | sc-401819-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (h2) | sc-401819-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (m) | sc-430993-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (m2) | sc-430993-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (m) | sc-430993-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (m2) | sc-430993-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (h) | sc-416704-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (h2) | sc-416704-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (h) | sc-416704-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (h2) | sc-416704-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (m) | sc-430271-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (m2) | sc-430271-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (m) | sc-430271-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (m2) | sc-430271-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |